http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104894224-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate | 2014-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104894224-B |
| titleOfInvention | Application of human CKIP1 gene and related medicine thereof |
| abstract | The invention discloses application of a human CKIP1 gene and related medicines thereof. The invention discloses an application of human CKIP1 gene in tumor treatment, tumor diagnosis and medicine preparation. The invention further constructs human CKIP1 gene small interfering RNA, human CKIP1 gene interfering nucleic acid construct, human CKIP1 gene interfering slow virus and discloses the application thereof. The siRNA or the nucleic acid construct containing the siRNA sequence and the lentivirus provided by the invention can specifically inhibit the expression of human CKIP1 gene, especially the lentivirus can efficiently infect target cells, efficiently inhibit the expression of CKIP1 gene in the target cells, further inhibit the growth of tumor cells and promote the apoptosis of the tumor cells, and have important significance in tumor treatment. |
| priorityDate | 2014-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 224.